Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec;8(2):e002567.
doi: 10.1136/rmdopen-2022-002567.

Mild COVID-19 despite inadequate antibody response after repeated vaccinations in rheumatic disease patients with rituximab-induced B cell depletion: a case series

Alexander Ten Hagen #  1 , Elisa Habermann #  1 , Sandra Hermann  1 , Gerd R Burmester  1 , Robert Biesen  1 , Fredrik N Albach  2
Affiliations

Mild COVID-19 despite inadequate antibody response after repeated vaccinations in rheumatic disease patients with rituximab-induced B cell depletion: a case series

Alexander Ten Hagen et al. RMD Open. 2022 Dec.
No abstract available

Keywords: Autoimmune Diseases; B-Lymphocytes; COVID-19; Rituximab; Vaccination.

PubMed Disclaimer

Conflict of interest statement

Competing interests: GRB is member of the Editorial Board of RMD Open.

References

    1. Calabrese CM, Kirchner E, Husni EM, et al. . Breakthrough SARS-CoV-2 infections in patients with immune-mediated disease undergoing B cell depleting therapy: a retrospective cohort analysis. Arthritis Rheumatol 2022;6. doi:10.1002/art.42287. [Epub ahead of print: 06 Jul 2022]. - DOI - PMC - PubMed
    1. Bitoun S, Avouac J, Henry J, et al. . Very low rate of humoral response after a third COVID-19 vaccine dose in patients with autoimmune diseases treated with rituximab and non-responders to two doses. RMD Open 2022;8:e002308. 10.1136/rmdopen-2022-002308 - DOI - PMC - PubMed
    1. Bitoun S, Henry J, Desjardins D, et al. . Rituximab impairs B cell response but not T cell response to COVID-19 vaccine in autoimmune diseases. Arthritis Rheumatol 2022;74:927–33. 10.1002/art.42058 - DOI - PMC - PubMed
    1. Gao Y, Cai C, Grifoni A, et al. . Ancestral SARS-CoV-2-specific T cells cross-recognize the omicron variant. Nat Med 2022;28:472–6. 10.1038/s41591-022-01700-x - DOI - PMC - PubMed
    1. Sigal A, Milo R, Jassat W. Estimating disease severity of omicron and delta SARS-CoV-2 infections. Nat Rev Immunol 2022;22:267–9. 10.1038/s41577-022-00720-5 - DOI - PMC - PubMed